New Report Analyzes Global Market for Optical Imaging Technologies

Research and Markets has announced the addition of the "Optical Imaging Market (2013-2018) - Technology and Market Analysis Of Optical Coherence Tomography (OCT), Hyper Spectral Imaging (HSI), Near Infrared Spectroscopy (NIRS) And Photo- Acoustic Tomography (PAT) In Clinical Diagnostics & Research" report to their offering.

The research service on "Advances in Optical Imaging in Clinical Diagnostics & Clinical Research - Technology Trends and Market Landscape Analysis" is an attempt to showcase the technology and market impact of existing and emerging optical imaging technologies having a huge growth potential in clinical medicine for the coming five years. This technology based research report categorizes optical imaging technologies based on applications, based on geography and on the basis of technicalities of various optical imaging modalities.

Based on Technology: For simplified and effective research, we categorized the entire breast imaging modalities into Ionizing breast imaging technologies and Non-ionizing breast imaging modalities based on the type of technicalities used in diverse breast screening modalities This report will cover the technological aspects of Optical Coherence Tomography (OCT), Photo - Acoustic Tomography (PAT), Near Infrared Spectroscopy (NIRS) and Hyper spectral Imaging (HSI) that are of huge interest to investors with high estimation time for investment opportunity outcomes. We have recognized several application areas for the emerging optical imaging technologies in the areas of ophthalmology, dentistry, neurology, cardiology, dermatology etc. Quantitative data analysis and growth rates provided for the North America and European market, potential addressable market for other technology segments mentioned in the report.

Global optical imaging market can be estimated to be approximately around $1.9 billion by end of 2018, growing at a CAGR of 11.37%. Among the modalities, OCT occupies a major share contributing over 70% of the total optical imaging market. America is the major market for optical imaging equipments followed by Europe, and they have been driving the market significantly owing to the growth of aging population across the developed economies. Other than the mature markets, emerging economies such as Asia-pacific and Middle-East are the future drivers of optical imaging market.

This report is further divided into segments and sub-segments providing exhaustive market analysis with respect to each technology from the years 2010 and 2011, as well as forecast up to 2018. Each technology is comprehensively analyzed at a granular level by geography (North America, EU, Asia and rest of the world) to provide in-depth information on the global scenario. Investment opportunity evaluation and emerging initial public offerings (IPOs) can be assessed within the optical imaging sector. Strategic recommendations for technology developers are elaborately discussed in this research service.

Challenges:

  • Inadequate clinical data validation for optical methods restricts adoption.
  • Lack of reimbursement facilities.

Companies Mentioned:

  • Ase Optics
  • Bioptigen, Inc.
  • Topcon Medical Systems, Inc.
  • Carl Zeiss Meditec
  • Chemimage Corporation
  • Cytoviva, Inc.
  • Headwall Photonics, Inc.
  • Heidelberg Engineering
  • Michelson Diagnostics Ltd ( Vivosight)
  • Raytheon Elcan Optical Technologies
  • Somanetics Corporation
  • St. Jude Medical
  • Volcano Corporation

For more information visit http://www.researchandmarkets.com/research/fzhbcw/optical_imaging

Source: http://www.researchandmarkets.com

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.